Becton Dickinson Votes for Biology
Executive Summary
Becton Dickinson, with huge shares in its core markets, has turned increasingly to research-intensive, high-payoff projects for its future growth. Its most ambitious program is in genetic diagnostics, where recent deals with The Institute for Genomic Research and Millennium Predictive Medicine have made it the diagnostics industry's highest-flying dealmaker. Its hope is to find the rarest and most valuable of all diagnostic products: a patented disease marker.